Table 3.
Results: patient-reported physical activity levels pre- and post-cancer treatment.
| Author and year | Measure | Categories | Pre-cancer treatment/diagnosis, n (%) | Post-cancer treatment/diagnosis (<6 months), n (%) | Post-cancer treatment/diagnosis (6–12 months), n (%) | Post-cancer treatment/diagnosis (>12 months), n (%) |
|---|---|---|---|---|---|---|
| Abbott 2018 | Recreational Physical Activity (adapted from IPAQ), MET-hours/week | 0 | 90 (34.1) | N/A | N/A | 130 (49.2) |
| >0–9 | 94 (35.6) | N/A | N/A | 90 (34.1) | ||
| >9 | 80 (30.3) | N/A | N/A | 44 (16.7) | ||
| Physical Activity Guidelines (PAG) for Americans | Meeting PAG | 65 (24.6) | N/A | N/A | 24 (9.1) | |
| Not meeting PAG | 199 (75.4) | N/A | N/A | 240 (90.9) | ||
| Beesley 2011 | Physical Activity Index | Low level (activity less than once/week) | 59 (22) | N/A | 109 (41) | 64 (24) |
| Medium level (strenuous activity once/week or moderate activity 1–3 times/week) | 101 (38) | N/A | 85 (32) | 109 (41) | ||
| High level (strenuous activity 2+ times/week or moderate activity 4+ times/week) | 106 (40) | N/A | 72 (27) | 93 (35) | ||
| Ryan 2012 | IPAQ, total hours/week, median (IQR) | Vigorous physical activity levels | 4 (2.8–9.5) | 3.0 (1.5–7.5) | N/A | N/A |
| Moderate physical activity levels | 5.5 (2.9–11.0) | 3.0 (1.0–9.0) | N/A | N/A | ||
| Walking | 3 (1.4–8.0) | 3.8 (2.5–8.3) | N/A | N/A | ||
| Total activity | 24.3 (15.6–49.5) | 14.8 (9.0–25.5) | N/A | N/A | ||
| Sitting | 4.0 (3.0–7.0) | 4.0 (3.0–5.0) | N/A | N/A | ||
| Farrokhzadi 2016 | Godin Leisure-Time Exercise Questionnaire, min/week | Vigorous | ||||
| None | 74 (76) | N/A | N/A | N/A | ||
| 1–120 | 14 (14) | N/A | N/A | N/A | ||
| >120 | 9 (9) | N/A | N/A | N/A | ||
| Moderate | ||||||
| None | 44 (45) | N/A | N/A | N/A | ||
| 1–120 | 23 (24) | N/A | N/A | N/A | ||
| 121–240 | 16 (16) | N/A | N/A | N/A | ||
| >240 | 14 (14) | N/A | N/A | N/A | ||
| Light | ||||||
| None | 45 (45) | N/A | N/A | N/A | ||
| 1–120 | 21 (21) | N/A | N/A | N/A | ||
| 121–240 | 17 (17) | N/A | N/A | N/A | ||
| >240 | 16 (16) | N/A | N/A | N/A | ||
| Total | ||||||
| None | 15 (16) | N/A | N/A | N/A | ||
| 1–120 | 21 (22) | N/A | N/A | N/A | ||
| 121–240 | 20 (21) | N/A | N/A | N/A | ||
| 241–480 | 23 (24) | N/A | N/A | N/A | ||
| >480 | 16 (17) | N/A | N/A | N/A | ||
| Active Australia Questionnaire, min/week | Inactive (0) | N/A | N/A | 12% | N/A | |
| Insufficiently active (1–149) | N/A | N/A | 35% | N/A | ||
| Sufficiently active (≥150) | N/A | N/A | 53% | N/A |
| Author and year | Measure | Categories | Changes in physical activity after cancer treatment, n (%) |
|---|---|---|---|
| Bifulco 2012 | Physical activity measured considering its frequency per year | GROUP A (young adults, between the ages of 18–45 years) | |
| No | 81 (76.4) | ||
| Reduction | 15 (14.1) | ||
| Increase | 10 (9.4) | ||
| Stop | 0 (0) | ||
| Start | 0 (0) | ||
| GROUP B (midlife adults, between the ages of 46–65 years) | |||
| No | 128 (81.5) | ||
| Reduction | 11 (7.0) | ||
| Increase | 7 (4.5) | ||
| Stop | 0 (0) | ||
| Start | 11 (7.0) | ||
| Mizrahi 2014 | A single item consisting of whether they were less, more, or similarly physically active compared with before their initial diagnosis | Less | 55 (58) |
| More | 15 (16) | ||
| Similar | 25 (26) |
Abbreviation: n, number of participants; IQR, inter-quartile range; %, percentage; N/A, not available; MET, metabolic equivalents; IPAQ, International Physical Activity Questionnaire; PAG, Physical Activity Guidelines for Americans.